1
项与 Dexamethasone 1.5% gamma-cyclodextrin(Oculis SA) 相关的临床试验A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of Two Doses of OCS 01 Compared to Vehicle in the Treatment of Inflammation and Pain Following Cataract Surgery
The DX-216 trial is a randomized, double-masked, placebo (vehicle)-controlled study evaluating the efficacy and safety of two doses of OCS-01 compared to vehicle in the treatment of inflammation and pain following cataract surgery. The primary objective is to evaluate the efficacy and safety of OCS-01 compared to placebo and the secondary objective is to evaluate the optimal dosing frequency (once a day [QD] or twice a day [BID]).
100 项与 Dexamethasone 1.5% gamma-cyclodextrin(Oculis SA) 相关的临床结果
100 项与 Dexamethasone 1.5% gamma-cyclodextrin(Oculis SA) 相关的转化医学
100 项与 Dexamethasone 1.5% gamma-cyclodextrin(Oculis SA) 相关的专利(医药)
100 项与 Dexamethasone 1.5% gamma-cyclodextrin(Oculis SA) 相关的药物交易